| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.053 | 0.5 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.5 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |